The DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Open accessAbstract
Pseudomonas aeruginosa is an important Gram-negative opportunistic pathogen which causes many severe acute and chronic infections with high morbidity, and mortality rates as high as 40%. What makes P. aeruginosa a particularly challenging pathogen is its high intrinsic and acquired resistance to many of the available antibiotics. In this review, we review the important acute and chronic infections caused by this pathogen. We next discuss various animal models which have been developed to evaluate P. aeruginosa pathogenesis and assess therapeutics against this pathogen. Next, we review current treatments (antibiotics and vaccines) and provide an overview of their efficacies and their limitations. Finally, we highlight exciting literature on novel antibiotic-free strategies to control P. aeruginosa infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Infection in Solid-Organ Transplant Recipients
Fishman, J. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064928 · Cited by 1,950
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C., Denham, C. R., & Bates, D. W. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9763 · Cited by 1,847
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry
Yin, I. X., Zhang, J., Zhao, I. S., Mei, M. L., Li, Q., & Chu, C. H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s246764 · Cited by 1,741
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Antibiotics versus biofilm: an emerging battleground in microbial communities
Sharma, D., Misba, L., & Khan, A. U. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0533-3 · Cited by 1,553
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
The antimicrobial peptides and their potential clinical applications.
Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019) · PubMed · Cited by 1,429
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Establishment of infection: lessons from a versatile opportunist
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01259-4 · Cited by 1,341
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
Picard, C., Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Conley, M. E., Cunningham-Rundles, C., Etzioni, A., Holland, S. M., Klein, C., et al. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0201-1 · Cited by 1,197
Dowd, S. E., Callaway, T. R., Wolcott, R. D., Sun, Y., McKeehan, T., Hagevoort, R. G., & Edrington, T. S. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-125 · Cited by 1,121
Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., Itani, K. M. F., Dellinger, P. E., Ko, C. Y., & Duane, T. M. (2017) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.10.029 · Cited by 1,101
Winsor, G. L., Griffiths, E. J., Lo, R., Dhillon, B. K., Shay, J. A., & Brinkman, F. S. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1227 · Cited by 1,050
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Skin microbiota: a source of disease or defence?
Cogen, A. L., Nizet, V., & Gallo, R. L. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08437.x · Cited by 952
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
Why chronic wounds will not heal: a novel hypothesis
Bjarnsholt, T., Kirketerp‐Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., Høiby, N., & Givskov, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00283.x · Cited by 886
Chemotherapy‐induced neutropenia: Risks, consequences, and new directions for its management
Crawford, J., Dale, D. C., & Lyman, G. H. (2004) · Cancer · doi:10.1002/cncr.11882 · Cited by 882
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Dowd, S. E., Sun, Y., Secor, P. R., Rhoads, D. D., Wolcott, B. M., James, G. A., & Wolcott, R. D. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-43 · Cited by 784
Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Conley, M. E., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Gaspar, H. B., Holland, S. M., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00162 · Cited by 748
Viral evasion and subversion of pattern-recognition receptor signalling
Bowie, A. G., & Unterholzner, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2436 · Cited by 746
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Tetracycline Antibiotics and Resistance
Grossman, T. H. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025387 · Cited by 725
Jones, R. N. (2010) · Clinical Infectious Diseases · doi:10.1086/653053 · Cited by 716
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M. (2016) · Nature Communications · doi:10.1038/ncomms10410 · Cited by 698
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
Winstanley, C., O’Brien, S., & Brockhurst, M. A. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.01.008 · Cited by 689
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.
Lambert, P. A. (2002) · Europe PMC (PubMed Central) · Cited by 677
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus
Serra, R., Grande, R., Butrico, L., Rossi, A., Settimio, U. F., Caroleo, B., Amato, B., Gallelli, L., & de Franciscis, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1023291 · Cited by 648
Diekema, D. J., Hsueh, P.-R., Mendes, R. E., Pfaller, M. A., Rolston, K. V., Sader, H. S., & Jones, R. N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-19 · Cited by 645
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
β-lactam antibiotics: An overview from a medicinal chemistry perspective
Lima, L. M., Silva, B. N. M. D., Barbosa, G., & Barreiro, E. J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112829 · Cited by 642
Multiple bacterial species reside in chronic wounds: a longitudinal study
Gjødsbøl, K., Christensen, J. J., Karlsmark, T., Jørgensen, B., Klein, B. M., & Krogfelt, K. A. (2006) · International Wound Journal · doi:10.1111/j.1742-481x.2006.00159.x · Cited by 622
Hyperbaric oxygen therapy for chronic wounds
Kranke, P., Bennett, M. H., Martyn-St James, M., Schnabel, A., Debus, S. E., & Weibel, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004123.pub4 · Cited by 622
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Pachori, P., Gothalwal, R., & Gandhi, P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.04.001 · Cited by 620
Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial
Lee, D. G., Urbach, J. M., Wu, G., Liberati, N. T., Feinbaum, R. L., Miyata, S., Diggins, L. T., He, J., Saucier, M., Déziel, E., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r90 · Cited by 603
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Pseudomonas aeruginosa Anaerobic Respiration in Biofilms
Yoon, S. S., Hennigan, R. F., Hilliard, G. M., Ochsner, U. A., Parvatiyar, K., Kamani, M. C., Allen, H. L., DeKievit, T. R., Gardner, P. R., Schwab, U., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00295-2 · Cited by 585
Shrivastava, S., Shrivastava, P., & Ramasamy, J. (2018) · Journal of Medical Society · doi:10.4103/jms.jms_25_17 · Cited by 583
Risk Factors and Causative Organisms in Microbial Keratitis
Green, M., Apel, A., & Stapleton, F. (2008) · Cornea · doi:10.1097/ico.0b013e318156caf2 · Cited by 555
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
Distribution, Organization, and Ecology of Bacteria in Chronic Wounds
Kirketerp-Møller, K., Jensen, P. Ø., Fazli, M., Madsen, K. G., Pedersen, J., Moser, C., Tolker-Nielsen, T., Høiby, N., Givskov, M., & Bjarnsholt, T. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00501-08 · Cited by 542
Tetracycline antibiotics and resistance mechanisms
Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0292 · Cited by 528
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac268 · Cited by 526
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome
Sutterwala, F. S., Mijares, L. A., Li, L., Ogura, Y., Kazmierczak, B. I., & Flavell, R. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071239 · Cited by 513
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth
Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S., Rogan, M. P., Davis, G. J., Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000928 · Cited by 495
Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 476
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
How do bacteria resist human antimicrobial peptides?
Peschel, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02333-8 · Cited by 465
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz, R. M., Schidlow, D. V., Wilmott, R. W., Astley, S. J., McBurnie, M. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282403 · Cited by 458
Polymyxin: Alternative Mechanisms of Action and Resistance
Trimble, M. J., Mlynárčik, P., Kolář, M., & Hancock, R. E. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025288 · Cited by 454
Clement, J. L., & Jarrett, P. S. (1994) · Metal-Based Drugs · doi:10.1155/mbd.1994.467 · Cited by 452
Diagnosis and management of osteomyelitis.
Carek, P. J., Dickerson, L. M., & Sack, J. L. (2001) · PubMed · Cited by 451
Bactericidal Activity of Different Honeys against Pathogenic Bacteria
Lusby, P. E., Coombes, A. L., & Wilkinson, J. M. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.03.038 · Cited by 451
Zhanel, G. G., Golden, A. R., Zelenitsky, S., Wiebe, K., Lawrence, C. K., Adam, H. J., Idowu, T., Domalaon, R., Schweizer, F., Zhanel, M. A., et al. (2019) · Drugs · doi:10.1007/s40265-019-1055-2 · Cited by 446
Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology
KONG, K., SCHNEPER, L., & MATHEE, K. (2010) · APMIS · doi:10.1111/j.1600-0463.2009.02563.x · Cited by 433
Bacterial elicitation and evasion of plant innate immunity
Abramovitch, R. B., Anderson, J. C., & Martin, G. B. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1984 · Cited by 429
Bhatt, S., & Chatterjee, S. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120440 · Cited by 428
Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.428-432.2001 · Cited by 426
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Picard, C., von Bernuth, H., Ghandil, P., Chrabieh, M., Levy, O., Arkwright, P. D., McDonald, D., Geha, R. S., Takada, H., Krause, J. C., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181fd8ec3 · Cited by 426
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
Motsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz530 · Cited by 422
Catheter-associated urinary tract infections
Warren, J. W. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00359-9 · Cited by 419
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Neurotoxic effects associated with antibiotic use: management considerations
Grill, M. F., & Maganti, R. K. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03991.x · Cited by 410
Hauser, A. R., Cobb, E., Bodí, M., Mariscal, D., Vallés, J., Engel, J. N., & Rello, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00005 · Cited by 399
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas, M. E., & Bliziotis, I. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.12.012 · Cited by 393
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
Ito, A., Nishikawa, T., Matsumoto, S., Yoshizawa, H., Sato, T., Nakamura, R., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-16 · Cited by 352
Responses of Pseudomonas aeruginosa to antimicrobials
Morita, Y., Tomida, J., & Kawamura, Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00422 · Cited by 344
Nathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
Obritsch, M. D., Fish, D. N., MacLaren, R., & Jung, R. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.10.1353 · Cited by 342
Taylor, P. K., Yeung, A. T. Y., & Hancock, R. E. W. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.003 · Cited by 340
Albrecht, C., Boutrot, F., Segonzac, C., Schwessinger, B., Gimenez-Ibanez, S., Chinchilla, D., Rathjen, J. P., de Vries, S. C., & Zipfel, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109921108 · Cited by 339
Oyibo, S. O., Jude, E. B., Tarawneh, I., Nguyen, H. C., Armstrong, D. G., Harkless, L. B., & Boulton, A. J. M. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00422.x · Cited by 338
Bacterial profile of ocular infections: a systematic review
Teweldemedhin, M., Gebreyesus, H., Atsbaha, A. H., Asgedom, S. W., & Saravanan, M. (2017) · BMC Ophthalmology · doi:10.1186/s12886-017-0612-2 · Cited by 337
Role of Pseudomonas aeruginosa type III effectors in disease
Engel, J., & Balachandran, P. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.12.007 · Cited by 330
A rat model of chronic respiratory infection with Pseudomonas aeruginosa.
Cash, H. A., Woods, D. E., McCullough, B., JOHANSON, W. G., & Bass, J. A. (1979) · PubMed · doi:10.1164/arrd.1979.119.3.453 · Cited by 327
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
Karaiskos, I., & Giamarellou, H. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.914172 · Cited by 324
A murine model of urinary tract infection
Hung, C.-S., Dodson, K. W., & Hultgren, S. J. (2009) · Nature Protocols · doi:10.1038/nprot.2009.116 · Cited by 323
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
Chegini, Z., Khoshbayan, A., Taati Moghadam, M., Farahani, I., Jazireian, P., & Shariati, A. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00389-5 · Cited by 321
Function of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
van Delden, C., Stampf, S., Hirsch, H. H., Manuel, O., Meylan, P., Cusini, A., Hirzel, C., Khanna, N., Weisser, M., Garzoni, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1113 · Cited by 319
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
Zhanel, G. G., Cheung, D., Adam, H., Zelenitsky, S., Golden, A., Schweizer, F., Gorityala, B., Lagacé-Wiens, P. R. S., Walkty, A., Gin, A. S., et al. (2016) · Drugs · doi:10.1007/s40265-016-0545-8 · Cited by 317
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Chatterjee, M., Anju, C. P., Biswas, L., Anil Kumar, V., Gopi Mohan, C., & Biswas, R. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.11.004 · Cited by 312
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Chung, D. R., Song, J.-H., Kim, S. H., Thamlikitkul, V., Huang, S.-G., Wang, H., So, T. M.-K., Yasin, R. M. D., Hsueh, P.-R., Carlos, C. C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0349oc · Cited by 310
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Nation, R. L., Velkov, T., & Li, J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu213 · Cited by 310
Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model
McVay, C. S., Velásquez, M., & Fralick, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-06 · Cited by 306
Epidemiology of Infections Due to Pseudomonas aeruginosa
Morrison, A. J., & Wenzel, R. P. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_3.s627 · Cited by 291
Falagas, M. E., & Karageorgopoulos, D. E. (2008) · Clinical Infectious Diseases · doi:10.1086/528867 · Cited by 290
Obritsch, M. D., Fish, D. N., MacLaren, R., & Jung, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4606-4610.2004 · Cited by 288
Freschi, L., Vincent, A. T., Jeukens, J., Emond-Rheault, J.-G., Kukavica-Ibrulj, I., Dupont, M.-J., Charette, S. J., Boyle, B., & Levesque, R. C. (2019) · Genome Biology and Evolution · doi:10.1093/gbe/evy259 · Cited by 286
Mwangi, J., Yin, Y., Wang, G., Yang, M., Li, Y., Zhang, Z., & Lai, R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909585117 · Cited by 286
Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7
Roy, P. H., Tetu, S. G., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q., Dodson, R., Harkins, D., Shay, R., Watkins, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008842 · Cited by 284
Sousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1797-1802.2004 · Cited by 277
Haidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Zhao, G., Hochwalt, P. C., Usui, M. L., Underwood, R. A., Singh, P. K., James, G. A., Stewart, P. S., Fleckman, P., & Olerud, J. E. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00608.x · Cited by 275
Vidal, F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440170139015 · Cited by 275
Riley, D. K., Classen, D. C., Stevens, L. E., & Burke, J. P. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80313-1 · Cited by 274
Impact of Siderophore Production on Pseudomonas aeruginosa Infections in Immunosuppressed Mice
Takase, H., Nitanai, H., Hoshino, K., & Otani, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1834-1839.2000 · Cited by 269
Raman, G., Avendano, E. E., Chan, J., Merchant, S., & Puzniak, L. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0370-9 · Cited by 269
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Liu, D., Van Belleghem, J. D., de Vries, C. R., Burgener, E., Chen, Q., Manasherob, R., Aronson, J. R., Amanatullah, D. F., Tamma, P. D., & Suh, G. A. (2021) · Viruses · doi:10.3390/v13071268 · Cited by 268
Micek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
Heeckeren, A., Walenga, R., Konstan, M. W., Bonfield, T., Davis, P. B., & Ferkol, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119828 · Cited by 262
Comolli, J. C., Hauser, A. R., Waite, L., Whitchurch, C. B., Mattick, J. S., & Engel, J. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3625-3630.1999 · Cited by 261
Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review
Kakasis, A., & Panitsa, G. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.004 · Cited by 261
Law, N., Logan, C., Yung, G., Furr, C.-L. L., Lehman, S. M., Morales, S., Rosas, F., Gaidamaka, A., Bilinsky, I., Grint, P., et al. (2019) · Infection · doi:10.1007/s15010-019-01319-0 · Cited by 260
The role of metabolism in bacterial persistence
Amato, S. M., Fazen, C. H., Henry, T. C., Mok, W. W. K., Orman, M. A., Sandvik, E. L., Volzing, K. G., & Brynildsen, M. P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00070 · Cited by 258
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Parkins, M. D., Somayaji, R., & Waters, V. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-18 · Cited by 253
Wood, S., Jayaraman, V., Huelsmann, E. J., Bonish, B., Burgad, D., Sivaramakrishnan, G., Qin, S., DiPietro, L. A., Zloza, A., Zhang, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091574 · Cited by 249
Self-citationInnate immune memory: towards a better understanding of host defense mechanisms
Quintin, J., Cheng, S.-C., van der Meer, J. W., & Netea, M. G. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.02.006 · Cited by 247
Antibacterial Potency of Honey
Albaridi, N. A. (2019) · International Journal of Microbiology · doi:10.1155/2019/2464507 · Cited by 239
Chatzinikolaou, I., Abi-Said, D., Bodey, G. P., Rolston, K. V. I., Tarrand, J. J., & Samonis, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.501 · Cited by 238
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections
Memar, M. Y., Yekani, M., Alizadeh, N., & Baghi, H. B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.142 · Cited by 234
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
Speert, D. P., Henry, D., Vandamme, P., Corey, M., & Mahenthiralingam, E. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0802.010163 · Cited by 232
The role of quorum sensing in the in vivo virulence of
Rumbaugh, K. P., Griswold, J. A., & Hamood, A. N. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01327-7 · Cited by 228
Dosler, S., & Karaaslan, E. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.021 · Cited by 226
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Razvi, S., Quittell, L., Sewall, A., Quinton, H., Marshall, B., & Saiman, L. (2009) · Chest · doi:10.1378/chest.09-0132 · Cited by 225
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis
Salsgiver, E. L., Fink, A. K., Knapp, E. A., LiPuma, J. J., Olivier, K. N., Marshall, B. C., & Saiman, L. (2016) · Chest · doi:10.1378/chest.15-0676 · Cited by 224
Bloodstream Infections Among Transplant Recipients: Results of a Nationwide Surveillance in Spain1
Moreno, A., Cervera, C., Gavaldá, J., Rovira, M., De La Cámara, R., Jarque, I., Montejo, M., De La Torre‐Cisneros, J., Miguel Cisneros, J., Fortún, J., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01964.x · Cited by 220
Neutrophil function in the healing wound: adding insult to injury?
Dovi, J., Szpaderska, A., & DiPietro, L. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-11-0720 · Cited by 217
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Rattanaumpawan, P., Lorsutthitham, J., Ungprasert, P., Angkasekwinai, N., & Thamlikitkul, V. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq360 · Cited by 211
Bacterial etiology of diabetic foot infections in South India
Shankar, E. M., Mohan, V., Premalatha, G., Srinivasan, R. S., & Usha, A. R. (2005) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.06.016 · Cited by 209
Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance
Ayoub Moubareck, C. (2020) · Membranes · doi:10.3390/membranes10080181 · Cited by 206
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
Nesher, L., & Rolston, K. V. I. (2014) · Infection · doi:10.1007/s15010-013-0525-9 · Cited by 202
Mouse models of cystic fibrosis: Phenotypic analysis and research applications
Wilke, M., Buijs-Offerman, R. M., Aarbiou, J., Colledge, W. H., Sheppard, D. N., Touqui, L., Bot, A., Jorna, H., De Jonge, H. R., & Scholte, B. J. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60020-9 · Cited by 198
Silver against Pseudomonas aeruginosa biofilms
BJARNSHOLT, T., KIRKETERP‐MØLLER, K., KRISTIANSEN, S., PHIPPS, R., NIELSEN, A. K., JENSEN, P. Ø., HØIBY, N., & GIVSKOV, M. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_646.x · Cited by 197
Al-Herz, W. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00054 · Cited by 194
Silver in Wound Care—Friend or Foe?: A Comprehensive Review
Khansa, I., Schoenbrunner, A. R., Kraft, C. T., & Janis, J. E. (2019) · Plastic and Reconstructive Surgery - Global Open · doi:10.1097/gox.0000000000002390 · Cited by 184
Contribution of Stress Responses to Antibiotic Tolerance in Pseudomonas aeruginosa Biofilms
Stewart, P. S., Franklin, M. J., Williamson, K. S., Folsom, J. P., Boegli, L., & James, G. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-15 · Cited by 182
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Kollef, M. H., Ricard, J.-D., Roux, D., Francois, B., Ischaki, E., Rozgonyi, Z., Boulain, T., Ivanyi, Z., János, G., Garot, D., et al. (2017) · Chest · doi:10.1016/j.chest.2016.11.026 · Cited by 173
Newman, J. W., Floyd, R. V., & Fothergill, J. L. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx124 · Cited by 172
Osmon, S., Ward, S., Fraser, V. J., & Kollef, M. H. (2004) · Chest · doi:10.1378/chest.125.2.607 · Cited by 171
Thaden, J. T., Park, L. P., Maskarinec, S. A., Ruffin, F., Fowler, V. G., & van Duin, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02671-16 · Cited by 168
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
Tumbarello, M., De Pascale, G., Trecarichi, E. M., Spanu, T., Antonicelli, F., Maviglia, R., Pennisi, M. A., Bello, G., & Antonelli, M. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2828-9 · Cited by 167
Bacterial colonization and healing of venous leg ulcers
Madsen, S. M., Westh, H., Danielsen, L., & Rosdahl, V. T. (1996) · APMIS · doi:10.1111/j.1699-0463.1996.tb04955.x · Cited by 164
Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection
Tal, S., Guller, V., Levi, S., Bardenstein, R., Berger, D., Gurevich, I., & Gurevich, A. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.04.004 · Cited by 162
Freschi, L., Jeukens, J., Kukavica‐Ibrulj, I., Boyle, B., Dupont, M.-J., Laroche, J., Larose, S., Maaroufi, H., Fothergill, J. L., Moore, M., et al. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01036 · Cited by 162
Honey: An Advanced Antimicrobial and Wound Healing Biomaterial for Tissue Engineering Applications
Mieles, J. Y., Vyas, C., Aslan, E., Humphreys, G. J., Diver, C., & Bártolo, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081663 · Cited by 162
Bacterial Pneumonia in Hospitalized Patients With HIV Infection
Afessa, B., & Green, B. (2000) · Chest · doi:10.1378/chest.117.4.1017 · Cited by 160
Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice
Watters, C., DeLeon, K., Trivedi, U., Griswold, J., Lyte, M., Hampel, K. J., Wargo, M. J., & Rumbaugh, K. P. (2012) · Medical Microbiology and Immunology · doi:10.1007/s00430-012-0277-7 · Cited by 157
Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model
Cafora, M., Deflorian, G., Forti, F., Ferrari, L., Binelli, G., Briani, F., Ghisotti, D., & Pistocchi, A. (2019) · Scientific Reports · doi:10.1038/s41598-018-37636-x · Cited by 156
Dalager‐Pedersen, M., Søgaard, M., Schønheyder, H. C., Nielsen, H. V., & Thomsen, R. W. (2014) · Circulation · doi:10.1161/circulationaha.113.006699 · Cited by 154
Adeno-associated virus–targeted disruption of the CFTR gene in cloned ferrets
Sun, X., Yan, Z., Yi, Y., Li, Z., Lei, D., Rogers, C. S., Chen, J., Zhang, Y., Welsh, M. J., Leno, G. H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34599 · Cited by 151
Dobias, J., Tendon, V. D., Poirel, L., & Nordmann, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3063-z · Cited by 151
Trdá, L., Boutrot, F., Claverie, J., Brulé, D., Dorey, S., & Poinssot, B. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00219 · Cited by 150
Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and systematic review
He, S., Chen, B., Li, W., Yan, J., Chen, L., Wang, X., & Xiao, Y. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.07.107 · Cited by 144
Robson, V., Dodd, S. R., & Thomas, S. (2009) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2008.04923.x · Cited by 144
Winkler, M., Papp‐Wallace, K. M., Hujer, A. M., Domitrovic, T., Hujer, K. M., Hurless, K. N., Tuohy, M. J., Hall, G. S., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04238-14 · Cited by 143
Vancanneyti, M., Witt, S., Abraham, W., Kersters, K., & Fredrickson, H. L. (1996) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(96)80025-7 · Cited by 142
Microbiological profile of infected diabetic foot ulcers
Y.Ge, D. M., Hait, H. I., Lipsky, B. A., ZASLOFF, M. A., & Holroyd, K. J. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00696_1.x · Cited by 142
What It Takes to Be a Pseudomonas aeruginosa? The Core Genome of the Opportunistic Pathogen Updated
Valot, B., Guyeux, C., Rolland, J. Y., Mazouzi, K., Bertrand, X., & Hocquet, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126468 · Cited by 141
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
Nation, R. L., Rigatto, M. H., Falci, D. R., & Zavascki, A. P. (2019) · Antibiotics · doi:10.3390/antibiotics8010024 · Cited by 140
Recurrent Pseudomonas aeruginosa Pneumonia in Ventilated Patients: Relapse or Reinfection?
Rello, J., Mariscal, D., March, F., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9703014 · Cited by 138
Haque, S., Ahmad, F., Dar, S. A., Jawed, A., Mandal, R. K., Wahid, M., Lohani, M., Khan, S. A., Singh, V., & Akhter, N. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.046 · Cited by 136
Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth, S., Ferrière, K., Hugonnet, S., Ricou, B., Suter, P., & Pittet, D. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.12.1353 · Cited by 135
Kielhofner, M. A., Atmar, R. L., Hamill, R. J., & Musher, D. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.403 · Cited by 135
A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene
Fan, Z., Périssé, I. V., Cotton, C. U., Regouski, M., Meng, Q., Domb, C., Wettere, A. J. V., Wang, Z., Harris, A., White, K. L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123529 · Cited by 135
Innate antimicrobial immunity in the skin: A protective barrier against bacteria, viruses, and fungi
Coates, M., Blanchard, S., & MacLeod, A. S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007353 · Cited by 134
Pseudomonas aeruginosa ventilator-associated pneumonia management
Rello, J., Ramirez‐Estrada, S., & Borgatta, B. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s50669 · Cited by 133
Niederman, M. S., Alder, J. D., Bassetti, M., Boateng, F., Cao, B., Corkery, K. J., Dhand, R., Kaye, K. S., Lawatscheck, R., McLeroth, P., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30574-2 · Cited by 132
Cited by
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Metadata
- Authors
- Wood, S. J., Kuzel, T. M., & Shafikhani, S. H.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-01-03
- Volume
- 12
- Issue
- 1
- Pages
- 199
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4313583227
- Cited by
- 254
- References
- 355
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.